Research
The Female Pelvic Health Center is dedicated to new developments in women’s health and is currently participating in the following national multicenter research studies in prolapse and stress incontinence procedures:
- Restorelle Transvaginal Mesh versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse 522 Study, Anterior/Apical Compartments, Restorelle 522 Study
- Restorelle Transvaginal Mesh versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse 522 Study, Posterior/Apical Compartments, Restorelle 522 Study
- The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the SHIP1 Pathway in Subjects with Interstitial Cystitis/Bladder Pain Syndrome Followed by a 40-Week Extension Period
- EMSELLA™ chair treatment for urinary incontinence
- The Neuguide System for Vaginal Colpopexy of Uterine Prolapse Post-arketing Surveillance Clinical Study
Several new studies including research in groundbreaking new procedures and medications for overactive bladder treatment are also on the horizon. Check back here for updates.
Dr. Stephanie Molden is motivated by the gratification of helping women with pelvic disorders—including pelvic organ prolapse, urinary and bladder problems—return to their normal lifestyle. She completed her training in Urogynecology with a three-year fellowship in a leading training program in the Lehigh Valley. Dr. Molden is an active member of the American Urogynecology Society (AUGS), participating in ongoing continuing education and research initiatives. 
